Core Roles of HTA

 
🩺 Assessing Therapeutic Value

Evaluates how a new health technology improves patient outcomes compared to the current standard of care. This is known as a Relative Effectiveness Assessment (REA).

💰 Pricing & Reimbursement

Uses both REA and economic evaluation to inform cost and coverage decisions.

 

HTA Across Europe

 
  • Multiple HTA bodies assess a wide range of technologies — from medicines and devices to digital health and complex interventions.
  • A 2018 European Commission study identified 56 public HTA organisations across 27 EU countries plus Norway.
  • These bodies differ based on health system structures and political environments, making their setups (origin, structure, function, remit, and approaches) unique to each country (or region or even province).